Valeant

Page 9 of 12

J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Leadership

Valeant CEO J. Michael Pearson Hospitalized for ‘Severe’ Pneumonia

By
December 26, 2015
Light snow falls on the Dow Chemical Co. Michigan Operations
Leadership

Shortchanging The Future

By
December 21, 2015
Janet Yellen Testifies Before House Financial Services Committee
Finance

End of Easy Money Brings Relief

By
December 17, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Valeant CEO Says Board Is ‘Welcome to Fire Me’

By
December 16, 2015
Oil Patch Woe and Fed Decision Looms–5 Things to Know Today
Tech

Oil Patch Woe and Fed Decision Looms–5 Things to Know Today

By Laura Lorenzetti and Geoffrey Smith
December 16, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Health

Valeant Has Hired a Crisis Management Firm

By
December 14, 2015
Cindy Whitehead, chief executive officer of Sprout Pharmaceuticals Inc., speaks during a Bloomberg Television interview in New York, U.S., on Wednesday, Aug. 19, 2015. Whitehead discussed Addyi, the company's pill for low libido in women that won approval from the U.S. Food and Drug Administration yesterday. Photographer: Chris Goodney/Bloomberg *** Local Caption *** Cindy Whitehead
MPW

CEO Behind ‘Female Viagra’ Leaves Company After Valeant Purchase

By
December 10, 2015
This Is What Happens When Cheap Drugs Get Wildly Expensive
Health

This Is What Happens When Cheap Drugs Get Wildly Expensive

By
December 9, 2015
Key Speakers At The Bloomberg Markets Most Influential Summit
Finance

Bill Ackman Just Boosted His Valeant Stake

By
November 24, 2015
SWITZERLAND-PHARMA-EARNINGS-COMPANY-NOVARTIS
Finance

Novartis Agrees to $390 Million Settlement

By
November 20, 2015
Police Operation in Saint Denis
Tech

Paris Siege and Square Prices IPO–5 Things to Know Today

By Laura Lorenzetti and Geoffrey Smith
November 18, 2015
Flibanserin
Health

Why ‘Female Viagra’ Is Not Selling

By
November 17, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Leadership

Mylan, Valeant and Theranos: What the Heck, Biotech?

By
November 13, 2015
Bill Ackman
Health

Valeant, Ackman Must Face U.S. Insider Trading Lawsuit

By
November 11, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Valeant CEO Defends Firm but Says He Doesn’t Have ‘Full Knowledge’

By
November 10, 2015

Most Popular